ROYAL BANK OF CANADA - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 57 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2018. The put-call ratio across all filers is 3.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$092
+64.3%
0.00%
Q4 2022$0
-100.0%
56
-98.9%
0.00%
Q1 2022$3,000
-84.2%
5,000
-75.0%
0.00%
Q3 2021$19,00020,000
+11199.4%
0.00%
Q4 2020$0177
+17600.0%
0.00%
Q3 2020$0
-100.0%
1
-100.0%
0.00%
Q2 2020$4,000
+33.3%
6,471
+0.5%
0.00%
Q1 2020$3,000
-25.0%
6,438
+28.8%
0.00%
Q4 2019$4,000
-20.0%
5,000
-17.5%
0.00%
Q3 2019$5,000
-28.6%
6,057
+21.1%
0.00%
Q2 2019$7,000
-36.4%
5,0000.0%0.00%
Q1 2019$11,0000.0%5,0000.0%0.00%
Q4 2018$11,000
-57.7%
5,000
-31.5%
0.00%
Q3 2018$26,000
+271.4%
7,304
+218.3%
0.00%
Q2 2018$7,000
-12.5%
2,2950.0%0.00%
Q1 2018$8,0002,295
+4230.2%
0.00%
Q4 2017$053
+341.7%
0.00%
Q3 2017$012
-89.0%
0.00%
Q3 2015$01090.0%0.00%
Q2 2015$0109
+2625.0%
0.00%
Q1 2015$040.0%0.00%
Q4 2014$040.0%0.00%
Q3 2014$040.0%0.00%
Q2 2014$04
-20.0%
0.00%
Q1 2014$05
+25.0%
0.00%
Q4 2013$040.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
GROW Partners, LLC 325,000$2,077,0001.27%
DAFNA Capital Management LLC 125,000$799,0000.82%
BARD ASSOCIATES INC 170,925$1,094,0000.46%
MARXE AUSTIN W & GREENHOUSE DAVID M 525,000$3,355,0000.36%
SOPHROSYNE CAPITAL LLC 42,000$267,0000.23%
Granite Point Capital Management, L.P. 205,000$1,310,0000.22%
SABBY MANAGEMENT, LLC 407,024$2,601,0000.17%
SCOGGIN MANAGEMENT LP 150,000$959,0000.08%
Geduld E E 25,000$160,0000.08%
PRELUDE CAPITAL MANAGEMENT, LLC 45,000$288,0000.05%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders